Exact Sciences pockets $238M from secondary stock sale — 3 key notes

Exact Sciences sold an additional 7 million shares for a gross proceeds of $245 million, the Wisconsin State Journal reports.

Here's what you should know:

1. After fees, Exact Sciences will make approximately $238 million.

2. Several investment firms can sell up to 1.05 million more shares of Exact Sciences if buyers demand it.

3. As of April 29, Exact Sciences had 111.2 million shares of common stock.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast